## **Core Concept**
Non-Hodgkin's lymphoma (NHL) is a heterogeneous group of lymphoid malignancies. The classification and prognosis of NHL can be understood based on the cell of origin, genetic features, and clinical presentation. The aggressiveness of NHL is often categorized into three groups: indolent (low-grade), intermediate, and aggressive (high-grade).

## **Why the Correct Answer is Right**
The correct answer, **B. Follicular lymphoma**, represents an intermediate form of Non-Hodgkin's lymphoma. Follicular lymphoma is a type of B-cell lymphoma characterized by the presence of the t(14;18) chromosomal translocation, leading to overexpression of the BCL2 protein, which inhibits apoptosis. This type of lymphoma typically presents with lymphadenopathy and has a relatively indolent course but is considered intermediate in terms of prognosis compared to the very indolent types like marginal zone lymphoma and the highly aggressive types like Burkitt lymphoma.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and does not provide a choice for evaluation.
- **Option C:** This option is also blank and does not provide a choice for evaluation.
- **Option D:** Similarly, this option is blank and does not offer a viable alternative.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the **International Prognostic Index (IPI)** and the **revised IPI (R-IPI)** are used to predict the prognosis of patients with aggressive NHL, including those with follicular lymphoma when it transforms or presents with more aggressive features. These indices take into account factors such as age, performance status, lactate dehydrogenase (LDH) levels, and the number of extranodal sites involved.

## **Correct Answer:** B. Follicular lymphoma.